JP2017529321A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017529321A5 JP2017529321A5 JP2017504368A JP2017504368A JP2017529321A5 JP 2017529321 A5 JP2017529321 A5 JP 2017529321A5 JP 2017504368 A JP2017504368 A JP 2017504368A JP 2017504368 A JP2017504368 A JP 2017504368A JP 2017529321 A5 JP2017529321 A5 JP 2017529321A5
- Authority
- JP
- Japan
- Prior art keywords
- colitis
- disease
- inflammatory bowel
- composition
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462029875P | 2014-07-28 | 2014-07-28 | |
| US62/029,875 | 2014-07-28 | ||
| PCT/EP2015/067306 WO2016016262A1 (en) | 2014-07-28 | 2015-07-28 | Methods and compositions for diagnosing and treating inflammatory bowel disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017529321A JP2017529321A (ja) | 2017-10-05 |
| JP2017529321A5 true JP2017529321A5 (enExample) | 2018-09-06 |
Family
ID=53762175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017504368A Withdrawn JP2017529321A (ja) | 2014-07-28 | 2015-07-28 | 炎症性腸疾患を診断ならびに処置するための方法および組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20180113139A1 (enExample) |
| EP (1) | EP3174895A1 (enExample) |
| JP (1) | JP2017529321A (enExample) |
| KR (1) | KR20170031245A (enExample) |
| CN (1) | CN106573056A (enExample) |
| AU (1) | AU2015295425A1 (enExample) |
| BR (1) | BR112017001971A2 (enExample) |
| CA (1) | CA2956683A1 (enExample) |
| MA (1) | MA40406A (enExample) |
| MX (1) | MX2017001293A (enExample) |
| WO (1) | WO2016016262A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2593939C2 (ru) | 2008-11-13 | 2016-08-10 | Ногра Фарма Лимитед | Антисмысловые композиции и способы их получения и применения |
| MX2021003681A (es) * | 2018-10-03 | 2021-08-19 | Akebia Therapeutics Inc | Composiciones y metodos para el tratamiento de desordenes inflamatorios. |
| CN115087455A (zh) * | 2019-11-12 | 2022-09-20 | 奥查德疗法(欧洲)有限公司 | 用于治疗或预防克罗恩病的组合物和方法 |
| AU2020384935A1 (en) * | 2019-11-15 | 2022-06-09 | Nogra Pharma Limited | IL-34 antisense agents and methods of using same |
| US11535655B2 (en) | 2019-12-06 | 2022-12-27 | Cheer Global Limited | Method of treating inflammatory bowel disease |
| TWI799840B (zh) | 2020-04-30 | 2023-04-21 | 美商美國禮來大藥廠 | 靶向介白素-34之化合物及方法 |
| AU2022276078A1 (en) | 2021-05-17 | 2024-01-04 | Nogra Pharma Limited | Il-34 antisense agents and methods of using same |
| CN118475610A (zh) | 2021-10-29 | 2024-08-09 | 伊莱利利公司 | 靶向白细胞介素-34的化合物和方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010062399A2 (en) * | 2008-11-26 | 2010-06-03 | Five Prime Therapeutics, Inc. | Csf1r extracellular domain fusion molecules and treatments using same |
| KR20140127855A (ko) * | 2012-02-06 | 2014-11-04 | 제넨테크, 인크. | Csf1r 억제제를 사용하는 조성물 및 방법 |
| CN107759690A (zh) * | 2012-08-31 | 2018-03-06 | 戊瑞治疗有限公司 | 用结合群落刺激因子1受体(csf1r)的抗体治疗病状的方法 |
-
2015
- 2015-07-28 CN CN201580041895.6A patent/CN106573056A/zh not_active Withdrawn
- 2015-07-28 JP JP2017504368A patent/JP2017529321A/ja not_active Withdrawn
- 2015-07-28 AU AU2015295425A patent/AU2015295425A1/en not_active Abandoned
- 2015-07-28 WO PCT/EP2015/067306 patent/WO2016016262A1/en not_active Ceased
- 2015-07-28 EP EP15744550.3A patent/EP3174895A1/en not_active Withdrawn
- 2015-07-28 BR BR112017001971A patent/BR112017001971A2/pt not_active Application Discontinuation
- 2015-07-28 CA CA2956683A patent/CA2956683A1/en not_active Abandoned
- 2015-07-28 KR KR1020177005114A patent/KR20170031245A/ko not_active Withdrawn
- 2015-07-28 MA MA040406A patent/MA40406A/fr unknown
- 2015-07-28 US US15/329,514 patent/US20180113139A1/en not_active Abandoned
- 2015-07-28 MX MX2017001293A patent/MX2017001293A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017529321A5 (enExample) | ||
| Adar et al. | From airway inflammation to inflammatory bowel disease: eotaxin-1, a key regulator of intestinal inflammation | |
| Spiering et al. | Comparative transcript profiling of Candida albicans and Candida dubliniensis identifies SFL2, a C. albicans gene required for virulence in a reconstituted epithelial infection model | |
| JP2010530852A (ja) | Ｉｌ−２０に関連する炎症性疾患を治療することにおける抗ｉｌ−２０抗体およびその使用 | |
| Sanders et al. | Epigenetic regulation of caveolin-1 gene expression in lung fibroblasts | |
| JP2006518991A5 (enExample) | ||
| CN110947003B (zh) | Gpr31抑制剂在制备治疗肾脏缺血再灌注损伤及相关疾病药物中的应用 | |
| Doki et al. | Therapeutic effect of anti-feline TNF-alpha monoclonal antibody for feline infectious peritonitis | |
| JP6721189B2 (ja) | ｖＷＦに結合するＤＮＡアプタマー | |
| BR112020007139A2 (pt) | tratamento de doença mediada por smc | |
| JP7391074B2 (ja) | 癌細胞に結合するｄｎａアプタマー | |
| US20190160067A1 (en) | Anti-htlv-1 drug and therapeutic agent for htlv-1-associated myelopathy/tropical spastic paraparesis (ham/tsp) | |
| CN110464844B (zh) | Alox12抑制剂在制备心脏缺血再灌注损伤治疗药物中的应用 | |
| CN115068612A (zh) | Drd2抑制剂在制备治疗与肝脏纤维化有关的疾病的药物中的应用 | |
| Choi et al. | Productive infection of dendritic cells by simian immunodeficiency virus in macaque intestinal tissues | |
| Bode et al. | Complement component C3 as a new target to lower albuminuria in hypertensive kidney disease | |
| KR20230088634A (ko) | 간암 특이적 바이오 마커 및 이의 용도 | |
| CN107326067A (zh) | 一种非酒精性脂肪肝的miRNA标记物 | |
| Zheng et al. | Treponema pallidum recombinant protein Tp47 activates NOD-like receptor family protein 3 inflammasomes in macrophages via glycolysis | |
| Wang et al. | The expression research of miR-210 in the elderly patients with COPD combined with ischemic stroke. | |
| JP2021505634A5 (enExample) | ||
| WO2016079321A1 (en) | Antagonists of setdb2 for use in the therapy of infectious diseases | |
| JP6986263B2 (ja) | 抗ウイルス薬 | |
| Middleton et al. | Resistance Profile Of ABT-333 And Relationship To Viral Load Decrease In Patients Treated In Combination With Peg-interferon And Ribavirin For 28 Days. | |
| IL296522A (en) | Compounds for treating or preventing a coronaviridae infection and methods and uses for assessing the occurrence of a coronaviridae infection |